Clinical Scorecard: Depression and Anxiety Symptoms in Adults With Type 1 Diabetes
At a Glance
| Category | Detail |
|---|---|
| Condition | Clinical topic addressed by the source article: Depression, anxiety symptoms may be common in T1D |
| Key Mechanisms | The study measured depressive and generalized anxiety symptoms using the PHQ-8 and GAD-7; it did not confirm clinical diagnoses. |
| Target Population | Population described in the source article. |
| Care Setting | Population-based analysis of 2019 and 2022 National Health Interview Survey data. |
Key Highlights
- In 2019 and 2022 National Health Interview Survey data, 17% of adults with type 1 diabetes reported moderate or severe depressive symptoms, compared with 12% with type 2 diabetes and 7% without diabetes.
- Moderate or severe generalized anxiety symptoms were reported by 16% of adults with type 1 diabetes, compared with 9% with type 2 diabetes and 6% without diabetes.
- Severe depressive symptoms were reported by 10% of adults with type 1 diabetes and severe generalized anxiety symptoms by 8%.
- Symptom prevalence varied by age, sex, and educational attainment; subgroup estimates were limited by the small type 1 diabetes sample. The survey did not assess diabetes-specific psychosocial burdens, which may overlap with depressive and anxiety symptoms.
- Symptoms were assessed over the preceding 2 weeks and were not confirmed through clinical interviews.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- The article reports the American Diabetes Association’s 2026 recommendation for annual depression and anxiety screening using validated instruments.
Risks
Patient & Prescribing Data
The analysis included 58,106 US adults: 326 classified as having type 1 diabetes, 5,802 as having type 2 diabetes, and the remainder without diabetes.
The article reports screening recommendations and symptom prevalence; it provides no medication or other treatment regimen.
Clinical Best Practices
- The article reports the ADA’s recommendation for annual depression and anxiety screening using validated instruments.
- The study used questionnaire symptom scores, not clinical interviews, to confirm diagnoses.
- The authors note possible diabetes-subtype misclassification, limited precision of type 1 diabetes subgroup estimates, and unmeasured diabetes-specific psychosocial burdens.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
